Muckenhuber, A. Et Al. 2018. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response. CLINICAL CANCER RESEARCH , vol.24, no.2 , 351-359.

Muckenhuber, A., Berger, A. K., Schlitter, A. M., Steiger, K., Konukiewitz, B., Trumpp, A., ... Eils, R.(2018). Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response. CLINICAL CANCER RESEARCH , vol.24, no.2, 351-359.

Muckenhuber, Alexander Et Al. "Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response," CLINICAL CANCER RESEARCH , vol.24, no.2, 351-359, 2018

Muckenhuber, Alexander Et Al. "Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response." CLINICAL CANCER RESEARCH , vol.24, no.2, pp.351-359, 2018

Muckenhuber, A. Et Al. (2018) . "Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response." CLINICAL CANCER RESEARCH , vol.24, no.2, pp.351-359.

@article{article, author={Alexander Muckenhuber Et Al. }, title={Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response}, journal={CLINICAL CANCER RESEARCH}, year=2018, pages={351-359} }